COLO B Coloplast A/S Class B

Coloplast awarded Enterostomal Therapy products agreement with Premier Inc.

Coloplast awarded Enterostomal Therapy products agreement with Premier Inc.

Coloplast, a global medical device company and market leader in intimate healthcare needs, has been awarded a three-year group purchasing agreement for ostomy products with Premier Inc. in the US.

The new agreement allows Premier members access to Coloplast’s full portfolio of ostomy products, including ostomy pouches and supporting products.

  • “We are delighted that Premier has added us to their Enterostomal Therapy contract. Coloplast shares Premier’s core values to improve patient outcomes and provide value to its customers, and we look forward to doing exactly that for Premier’s membership,” says Senior Vice President Manu Varma, Chronic Care North America.

The agreement is multi-source and effective for three years beginning April 1, 2020. Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and hospital systems and more than 175,000 other providers to transform healthcare.

About Coloplast ostomy care products

Coloplast’s range of innovative ostomy products are designed to reduce leakage and maintain healthy skin. With the SenSura® Mio portfolio and BodyFit® Technology Coloplast has taken fit, flexibility, and comfort to a new level, creating a portfolio of innovative ostomy solutions that reduce the burden of leakage and enable users to live the life they want to lead.

In addition to product solutions, Coloplast has developed Coloplast® Care, the only patient support program option with better patient outcomes. Coloplast Care provides ostomy users access to education and tools for self-assessment and individualized support from Care Advisors. Coloplast Care provides reliable information so ostomy users can better manage their care and experience a full life.

About Coloplast

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions.

Learn more on

Global press contact

Lina Danstrup, Senior Media Relations Manager



   

Ellen Bjurgert, Vice President, Investor Relations



Attachment

EN
07/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch